Board Members

Anders Tullgren

Chairman of The Board

Anders has over 30 years of global experience in the pharmaceutical industry and has had senior leadership roles in the United States, Germany, France, the United Kingdom and the Nordic region. The latest role he left in 2017 was as President of the Intercontinental region of Bristol Myers Squibb with responsibility for over 30 countries, 5,000 employees and a turnover of over 20 billion. He is board member of Trialbee AB, Sweden and BrandingScience Ltd, UK. He holds a MSc in Pharmacy from Uppsala University.

Chairman of the Board since 2018.

Shares: 32,857

Warrants: 49,285

Independent in relation to the company and company management and major shareholders

Prof. Saeid Esmaeilzadeh

Board Member

Saeid is a serial entrepreneur having established and managed a range of research-intensive companies in various industries. In 2002 he became the youngest associate professor in Sweden. He has received many distinctions and awards for his research as well as for his achievements as an entrepreneur. Saeid is an experienced board member and since 2010 has been the CEO of Serendipity Innovations. Saeid has a Ph.D. in Materials Chemistry from Stockholm University.

Board member since 2018,
former Chairman of the Board 2008-2018.

Shares: 712,088 (direct: 28,759, indirect: 683,329)

Independent in relation to the company and company management and but non-independet in relation to the company major shareholders

Declined re-election 2019

Prof. Maris Hartmanis

Board Member

Maris is a seasoned industrial executive and leader with almost 30 years of CEO, senior R&D management and Board of Director experience from the international Life Science area. His experience stems from large organizations, as well as entrepreneurial start-ups. Most recently he was the CEO of two Swedish public pharmaceutical companies. Maris has a Ph.D. degree in Biochemistry from the Royal Institute of Technology in Stockholm, where he also is an Associate Professor.

Board member since 2015.

Shares: 7,500

Warrants: 2,250

Independent in relation to the company and company management and major shareholders

Karin Wingstrand

Board Member

Karin has a broad experience of the international pharmaceutical industry from senior positions within regulatory, pharmaceutical and analytical R&D, project leadership as well as clinical. Most recently Karin held the position of Global Head and Vice President of Clinical Development at AstraZeneca.

Board member since 2015.

Shares: 7,900

Warrants: 3,000

Independent in relation to the company and company management and major shareholders

Prof. Peter Edman

Board Member

Peter has an extensive experience in drug development from the pharmaceutical industry and has held a number of senior research leadership positions within Orexo, Sobi, Biovitrum, AstraZeneca, Astra and Pharmacia. He has also held a position as Associate Professor at the Swedish Medical Product Agency. In addition, Peter has been Professor in Pharmaceutical Formulation and Adjunct Professor in Drug Delivery at the Faculty of Pharmacy, University of Uppsala.

Board member since 2015.

Shares: 7,500

Warrants: 2,250

Independent in relation to the company and company management and major shareholders

Giorgio Chirivi

Board Member

Giorgio is educated in finance and business administration at the University Luigi Bocconi in Italy and operates as Head of Mergers & Acquisitions at UBI Banca SpA. Giorgio also has a board assignment for Axxam SpA.

Board member since 2016.

Shares: 2,000

Warrants: 3,000

Independent in relation to the company and company management and major shareholders

Alessandro Sidoli

Board Member

Alessandro is educated in biology at Pavia University in Italy and operates as CEO of Axxam SpA. Alessandro also has board assignments for FEDERCHIMICA, Italian Association of Business Angels, ALISEI and Externautics SpA.

Board member since 2016.

Shares: 76,885

Warrants: 3,000

Independent in relation to the company and company management and major shareholders

Declined re-election 2019